Amgen - Targeting KRASG12C: A new era for patients with advanced NSCLC Industry Satellite Symposium

The turning point: Practical considerations when emerging biomarkers become actionable (ID 328)

Lecture Time
11:50 - 12:05
Speakers
  • Keith M. Kerr, Aberdeen, GB
Session Name
Amgen - Targeting KRASG12C: A new era for patients with advanced NSCLC
Location
South Hall 2, Prague Congress Centre, Prag, Czech Republic
Date
Wed, 30.03.2022
Time
11:30 - 13:00